MDR MICRORGANISMS: BAD BUGS, NO DRUGS?
From an infectious diseases point of view this is one of the key sessions at this year’s LIVES meeting. Multidrug resistance is now a reality in most ICUs around the world. Although factors contributing to MDR have been identified, we apparently are not able to eradicate this problem, and patients are increasingly exposed to MDR pathogens. It is highly unlikely that we will see less MDR in the future.
In the session ‘Antimicrobial resistance: Bad bugs, no drugs?’ world-renowned experts will discuss both the current status of the problem and possible solutions.This essential session will kick off with an overview of the current epidemiology from a global perspective. Antibiotic pressure and cross transmission contribute to MDR development and spread and are targets to at least slow down the problem and will be covered as well. Treating patients with MDR infections is equally challenging. The last presentations in the session will review current treatment strategies for Gram-positive and Gram- negative MDR infections.
This session will bring the audience up to date with this pressing problem, review strategies to prevent or slow down MDR, as well as offer guidance for the treatment of MDR infections.
Take home messages from this session:
• MDR has been identified as one of the most urgent global public health problems by several international agencies and organisations.
• ICUs are the epicenter of MDR due to the high use of antibiotics, increased risk of transmission and impaired host response of the patient.
• Preventing the spread of MDR should be a priority in any ICU
• Intensivists need to know how to stop resistance spread and adequately treat MDR infected patients.
Thematic Session ~ MDR MICRORGANISMS: BAD BUGS, NO DRUGS?
01.10.2014, 08:30 – 10:00 - room Glasgow<Back to the news list